Tagged nci

New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care
Press Release

New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care

 Reveal Pharmaceuticals doses first subjects in Phase 1 Clinical Trial of RVP-001 Read More
Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant
Press Release

Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant

 Read More
Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition
Press Release

Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition

 Read More
Press Release

President and Executive Director Assume New Roles at the Children's Cancer Foundation, Inc.

 Read More
Privo Technologies Receives a $3M Award
Press Release

Privo Technologies Receives a $3M Award

 Read More
Lazarex Cancer Foundation's Founder and President Dana Dornsife Met With Greg Simon the Executive Director of the Cancer Task Force in the Office of the Vice President of the United States
Press Release

Lazarex Cancer Foundation's Founder and President Dana Dornsife Met With Greg Simon the Executive Director of the Cancer Task Force in the Office of the Vice President of the United States

 The meeting highlighted Lazarex Cancer Foundation's new iMPACT pilot program, which is working to improve patient enrollment, retention, and minority member participation in oncology clinical trials especially among underserved populations. Read More
Press Release

The Clinical Data Interchange Standards Consortium (CDISC) & US National Cancer Institute - Enterprise Vocabulary Services (NCI EVS) to Collaborate on the Development of CDISC SHARE

 The CDISC Shared Health And Clinical Research Electronic Library (CDISC SHARE) is envisioned as a global, accessible, electronic library. Read More
Press Release

Oncolytics Biotech® Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute

 The Study Chair will be Dr. David E. Cohn of The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Read More